Drug Profile
GSK 656398
Alternative Names: GSK-656398; TD-5742Latest Information Update: 01 Aug 2023
Price :
$50
*
At a glance
- Originator Theravance
- Class Bronchodilators
- Mechanism of Action Muscarinic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Chronic obstructive pulmonary disease
Most Recent Events
- 12 May 2006 Discontinued - Phase-I for Chronic obstructive pulmonary disease in USA (Inhalation)
- 19 Aug 2005 Phase-I clinical trials in Chronic obstructive pulmonary disease in USA (Inhalation)
- 31 Jul 2004 Preclinical trials in Chronic obstructive pulmonary disease in USA (Inhalation)